P&G seals $3.8bn deal for supplements company Thorne - Financial Times

Core Impact Points

• P&G has acquired Thorne, a supplements company, for $3.8 billion.
• The acquisition is expected to boost P&G's health care portfolio and cater to the growing demand for health supplements in the US.
• Thorne's products will be integrated into P&G's existing health care portfolio, expanding its presence in the wellness market.
• The deal is seen as a strategic move by P&G to tap into the lucrative wellness industry, which is expected to continue growing in the US.
• P&G's acquisition of Thorne is a significant move in the health and wellness space, and is likely to have implications for the US market and consumers.